|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
1993-11-19
|
|
pubmed:abstractText |
Nonsteroidal anti-inflammatory drug (NSAID) use is increasingly recognized as a major factor associated with peptic ulcer disease and complications. We undertook a multicenter, double-blind, placebo-controlled trial to evaluate efficacy and safety of nizatidine in preventing ulcer formation in patients with osteoarthritis who were taking NSAIDs.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0003-9926
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
8
|
|
pubmed:volume |
153
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2449-54
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8215749-Adult,
pubmed-meshheading:8215749-Aged,
pubmed-meshheading:8215749-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:8215749-Double-Blind Method,
pubmed-meshheading:8215749-Endoscopy, Digestive System,
pubmed-meshheading:8215749-Female,
pubmed-meshheading:8215749-Humans,
pubmed-meshheading:8215749-Male,
pubmed-meshheading:8215749-Middle Aged,
pubmed-meshheading:8215749-Nizatidine,
pubmed-meshheading:8215749-Osteoarthritis,
pubmed-meshheading:8215749-Peptic Ulcer
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs.
|
|
pubmed:affiliation |
Lilly Research Laboratories, Eli Lilly and Co, Indianapolis, Ind.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
